Trade this ETF at your broker
Index | MSCI China All Shares Health Care 10/40 |
Investment focus | Azioni, Cina, Salute |
Fund size | EUR 2 m |
Total expense ratio | 0,65% annuo |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 22,98% |
Inception/ Listing Date | 14 gennaio 2021 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Irlanda |
Fund Provider | KraneShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | - |
Investment Advisor | |
Custodian Bank | - |
Revision Company | - |
Fiscal Year End | - |
Swiss representative | Waystone Fund Services (Switzeland) SA |
Swiss paying agent | Helvetische Bank AG |
Germany | Non noto |
Switzerland | Non |
Austria | Non noto |
UK | Dichiara nel Regno Unito |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Wuxi Biologics Cayman | 9,62% |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 6,79% |
BeiGene Ltd. | 4,66% |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 4,18% |
CSPC Pharmaceutical Group Ltd. | 4,05% |
Aier Eye Hospital Group Co., Ltd. | 3,62% |
WuXi AppTec Co., Ltd. | 3,56% |
Zhangzhou Pientzehuang | 3,00% |
Chongqing Zhifei | 2,41% |
Sino Biopharmaceutical Ltd. | 2,40% |
Cina | 89,88% |
Cayman Islands | 4,66% |
Hong Kong | 3,42% |
Altri | 2,04% |
Salute | 98,48% |
Industria | 0,47% |
Altri | 1,05% |
YTD | -11.26% |
1 month | +6.60% |
3 months | +0.50% |
6 months | -17.41% |
1 year | -24.40% |
3 years | -55.09% |
5 years | - |
Since inception (MAX) | -50.76% |
2023 | -20.34% |
2022 | -20.98% |
2021 | - |
2020 | - |
Volatility 1 year | 22.98% |
Volatility 3 years | 27.92% |
Volatility 5 years | - |
Return per risk 1 year | -1.06 |
Return per risk 3 years | -0.84 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -32.58% |
Maximum drawdown 3 years | -62.61% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -62.98% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
Borsa Italiana | EUR | KURE | - - | - - | - |
XETRA | EUR | KRUE | - - | - - | - |
London Stock Exchange | USD | KURE | KURE LN | FlowTraders |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Global X China Biotech UCITS ETF USD Accumulating | 0 | 0.68% p.a. | Accumulating | Full replication |